🤝 Connected Health Tech - Commure Nexus Recap

This article summarizes the first Commure Nexus event, featuring insights from General Catalyst on the future of connected health technology. A link to General Catalyst's May recap is provided for further details.

Key Points:

• Collaboration on the future of connected health tech.

• Insights into General Catalyst's perspective on Nexus.

• Overview of General Catalyst's other achievements.

🔗 Resources:

• General Catalyst May Recap ↗ - Insights from General Catalyst

Image

💡 Healthcare - Reimagining Doctor-Patient Interaction

This article discusses a vision for the future of healthcare, focusing on increasing the number of doctor-patient touchpoints through technological advancements. The author expresses excitement about removing labor constraints and emphasizing personalized, empathetic care.

Key Points:

• Vision for increased doctor-patient interaction.

• Focus on personalized and empathetic care.

• Removing labor constraints as a limiting factor.

💡 Oncology - AI Dissemination in Healthcare

This article highlights the importance of rigorous standards for the dissemination of AI in oncology, emphasizing the need for thorough research and evaluation comparable to traditional medical advancements.

Key Points:

• Emphasis on high standards for AI in oncology.

• Comparison to traditional research and conference presentations.

• Advocating for a robust evaluation process for AI tools.

🔬 Geriatric Exercise - Square Stepping and Physical Function

This article summarizes a study examining the effects of a 12-week square stepping exercise program on physical function, fall risk, and biomarkers in older women.

Key Points:

• Improved balance and gait speed.

• Reduced fear of falling.

• No significant changes in EEG and SMP30 levels.

🔗 Resources:

• Full Study ↗ - Research findings

🚀 Intracerebral Hemorrhage (ICH) Care - Reducing Transfer Times

This article describes a hospital system's success in reducing intracerebral hemorrhage (ICH) transfer times by nearly 50% through the integration of Viz AI into their NEMAT workflow. A link to register for a webinar detailing this implementation is included.

Key Points:

• Nearly 50% reduction in ICH transfer times.

• Successful integration of Viz AI into NEMAT workflow.

🚀 Implementation:

Integrate Viz AI: Incorporate Viz AI into the existing NEMAT workflow.
Optimize Workflow: Adjust processes to maximize the benefits of Viz AI.
Monitor Outcomes: Track transfer times and other relevant metrics.

🔗 Resources:

• Webinar Registration ↗ - Details on ICH care improvement

Image

🤖 Cancer Detection - AI in Pathology Labs

This article discusses the potential of AI in improving early cancer detection and management, highlighting the perspective of Alverno Laboratories CEO Sam Terese and featuring an image from Pathologist Magazine.

Key Points:

• AI's potential for earlier cancer detection.

• Improved cancer management through AI.

• Recommendation for widespread AI adoption in labs.

🔗 Resources:

Image

🤖 Wearable Technology - Streaming Camera Data via Bluetooth

This article describes the implementation of camera support in a software development kit (SDK) for smart insoles, enabling streaming of camera data from smart glasses to a smartwatch via Bluetooth.

Key Points:

• Camera support added to smart insole SDK.

• Streaming camera data from smart glasses to smartwatch.

• Functionality demonstrated on Apple Watch Series 5.

🔗 Resources:

Image

🔬 Oncology - DESTINY-Breast09 Trial Results

This article presents key findings from the DESTINY-Breast09 trial (LBA1008) on the treatment of HER2-positive metastatic breast cancer, highlighting improved progression-free survival and a comparable safety profile.

Key Points:

• Improved median progression-free survival (PFS).

• Similar safety profiles between treatment groups.

• Incidence of interstitial lung disease (ILD).

🔗 Resources:

Image

🔬 Oncology - CheckMate 816 Trial 5-Year Outcomes

This article presents 5-year overall survival (OS) data from the CheckMate 816 trial on neoadjuvant nivolumab plus chemotherapy in non-small cell lung cancer (NSCLC), discussing the clinical significance of these results, particularly in PD-L1-negative patients.

Key Points:

• Improved 5-year overall survival (OS).

• High pCR rate associated with improved OS.

• Benefit observed in PD-L1 ≥1% patients.

🔗 Resources:

Image

🤖 Oncology - L3 Skeletal Muscle Index in CT Imaging

This article announces the publication of a new e-abstract at ASCO25, focusing on the technical performance of the L3 Skeletal Muscle Index (SMI) in CT imaging as a muscle mass biomarker relevant to oncology outcomes.

Key Points:

• Focus on the L3 SMI as a muscle mass biomarker.

• Evaluation of reliability and accuracy in CT imaging.

• Relevance to oncology outcomes.

🔗 Resources:

• ASCO Abstract ↗ - Study details

⭐️ Support

If you liked reading this report, please star ⭐️ this repository and follow me on Github ↗, 𝕏 (previously known as Twitter) ↗ to help others discover these resources and regular updates.